Physicians Misinterpret Drug Efficacy Due to Framing of Risk Data, Study Shows
A recent study highlights that physicians frequently misinterpret the effectiveness of drugs due to how risk reduction data is presented. When drug efficacy is framed as a relative risk reduction (e.g., 'reduces mortality by one-third'), doctors are significantly more likely to rate the drug as highly effective compared to when the identical data is presented as an absolute risk reduction (e.g., 'lowers mortality from 6 percent to 4 percent'). This cognitive bias, also observed in patients, leads to an overestimation of treatment benefits. For instance, a 50 percent relative risk reduction might translate to only a 1 percent absolute risk reduction over five years, a detail often overlooked. The issue extends to industry influence, as research indicates that even small financial incentives, like sponsored meals, can correlate with increased prescribing of promoted brand-name drugs, further complicating objective assessment of drug benefits. The article emphasizes that while relative risk reductions are tec...